Case Study: An Unusual Presentation of Smoldering Multiple Myeloma in a Patient With End-Stage Renal Disease
K Golab, L Carrillo-Polanco - American Society for Clinical …, 2019 - clsjournal.ascls.org
ABSTRACT A 59-year-old male patient was presented to the benign hematology clinic with
a chief complaint of persistent macrocytic anemia with mild thrombocytopenia of unclear …
a chief complaint of persistent macrocytic anemia with mild thrombocytopenia of unclear …
Diagnosis of smoldering multiple myeloma
SV Rajkumar, D Larson, RA Kyle - New England journal of …, 2011 - Mass Medical Soc
Diagnosis of Smoldering Multiple Myeloma Page 1 The new england journal of medicine n
engl j med 365;5 nejm.org august 4, 2011 474 scribers with accurate and unbiased …
engl j med 365;5 nejm.org august 4, 2011 474 scribers with accurate and unbiased …
Multiparameter Flow Cytometry Immunophenotyping for the Identification of Smoldering Multiple Myeloma: A Case Report
S Tarafder - International Research Journal of Oncology, 2021 - archive.pcbmb.org
Smoldering multiple myeloma (SMM) is a clonal plasma cell (PC) condition that falls
between monoclonal gammopathy of unknown significance (MGUS) and multiple myeloma …
between monoclonal gammopathy of unknown significance (MGUS) and multiple myeloma …
[HTML][HTML] A case with hepatic involvement mimicking metastatic disease in multiple myeloma
M Erciyestepe, TO Tiryaki… - Case Reports in …, 2020 - hindawi.com
Multiple myeloma is a type of plasma cell disorder and can be seen in different forms.
According to current knowledge, it is not a curable disease. Smoldering multiple myeloma …
According to current knowledge, it is not a curable disease. Smoldering multiple myeloma …
[PDF][PDF] Case Report A Case with Hepatic Involvement Mimicking Metastatic Disease in Multiple Myeloma
M Erciyestepe, TO Tiryaki, IY Hindilerden, G Yegen… - 2020 - academia.edu
Multiple myeloma is a type of plasma cell disorder and can be seen in different forms.
According to current knowledge, it is not a curable disease. Smoldering multiple myeloma …
According to current knowledge, it is not a curable disease. Smoldering multiple myeloma …
A Case with Hepatic Involvement Mimicking Metastatic Disease in Multiple Myeloma
TO Tiryaki, G Yegen, IY Hindilerden, M Nalcaci… - acikerisim.istanbul.edu.tr
Multiple myeloma is a type of plasma cell disorder and can be seen in different forms.
According to current knowledge, it is not a curable disease. Smoldering multiple myeloma …
According to current knowledge, it is not a curable disease. Smoldering multiple myeloma …
The Natural History of Smoldering (Asymptomatic) Multiple Myeloma.
R Kyle, E Remstein, T Therneau, A Dispenzieri… - Blood, 2005 - Elsevier
Smoldering multiple myeloma (SMM) is characterized by a serum M protein≥ 3g/dL and/or
10% or more of plasma cells in the bone marrow. However, the definition is not …
10% or more of plasma cells in the bone marrow. However, the definition is not …
[HTML][HTML] Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma
RA Kyle, ED Remstein, TM Therneau… - … England Journal of …, 2007 - Mass Medical Soc
Background Smoldering (asymptomatic) multiple myeloma is an asymptomatic plasma-cell
proliferative disorder associated with a high risk of progression to symptomatic multiple …
proliferative disorder associated with a high risk of progression to symptomatic multiple …
Smoldering Multiple Myeloma Presenting as Immune Thrombocytopenia
A Jain, JM Khunger, S Kapahtia, P Prasad… - Indian Journal of …, 2019 - Springer
Cytopenias associated with plasma cell dyscrasia are usually either disease-related
(replacement of marrow hematopoiesis by clonal plasma cells) or therapy-related …
(replacement of marrow hematopoiesis by clonal plasma cells) or therapy-related …
New approaches to smoldering myeloma
MV Mateos, JF San Miguel - Current hematologic malignancy reports, 2013 - Springer
Smoldering multiple myeloma (SMM) is an asymptomatic plasma cell disorder characterized
by the presence of one or both features of serum M-protein≥ 30 g/L and bone marrow …
by the presence of one or both features of serum M-protein≥ 30 g/L and bone marrow …